Human NAD+ Bioavailability
Recent randomized, double-blind, placebo-controlled human clinical trials definitively confirm that oral supplementation of NAD+ precursors efficiently reverses age-related systemic decline, stimulates cellular metabolism, and enhances vascular health in healthy adults.
Clinical Specs
250 mg/day dosage demonstrates optimal safety with zero adverse effects over long-term evaluations.